Abstract:. In updated phase I clinical trial results, patients treated with zoldonrasib, a KRASG12D-selective inhibitor under study in non–small cell lung cancer, showed an objective response rate of ...
You do not currently have access to this content.
Cancer Res (2026) 86 (7_Supplement): 5811.
2Department of Radiation Oncology, Stanford University, Stanford, California.
Abstract. Antibody-drug conjugates (ADCs) enable the specific targeting of a potent cytotoxic drug to cancer cells expressing a select antigen via the release of the cytotoxin covalently linked to a ...
School of Pharmaceutical Sciences - USM, Penang, Malaysia.
Search for other works by this author on: ...
Nemours Children's Health, Orlando, FL.
Abstract:. An artificial intelligence model called Clairity Breast, which uses mammogram images to predict the 5-year likelihood of breast cancer, was recently launched in Massachusetts. The first to ...
Search for other works by this author on: ...
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results